Advisor Group’s Histogen HSTO Stock Holding History
Bought
Maintained
Sold
Other funds holding HSTO
JC
Advisor Group's HSTO Position: Q4 2019 in Review
Advisor Group held its Histogen (HSTO) position steady in Q4 2019 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5523.
Advisor Group first reported a position in HSTO in Q3 2017 and has held it in 8 quarters since. The position peaked at $6K in Q3 2018. 28 funds tracked by Wall St. Rank hold HSTO as of Q4 2019.
- Advisor Group held 5 shares of Histogen worth $0 as of Q4 2019.
- Advisor Group left its Histogen share count unchanged in Q4 2019.
- Histogen made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5523 holding.
- Advisor Group first reported a position in Histogen in Q3 2017 and has held it in 8 quarters since.
- Advisor Group's Histogen position peaked at $6K in Q3 2018.
- 28 funds tracked by Wall St. Rank held Histogen as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.